Sulfafurazole
Not to be confused with sulfadiazine.
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide  | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| MedlinePlus | a601049 | 
| Pregnancy category  | 
  | 
| Legal status | 
  | 
| Routes of administration  | Oral | 
| Pharmacokinetic data | |
| Excretion | Excreted unchanged in urine | 
| Identifiers | |
| CAS Number | 
127-69-5  | 
| ATC code | J01EB05 S01AB02 QJ01EQ05 | 
| PubChem | CID 5344 | 
| DrugBank | 
DB00263  | 
| UNII | 
740T4C525W  | 
| KEGG | 
D00450  | 
| ChEMBL | 
CHEMBL453  | 
| Chemical data | |
| Formula | C11H13N3O3S | 
| Molar mass | 267.30 g/mol | 
  | |
| Physical data | |
| Melting point | 194 °C (381 °F) | 
|   | |
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
Synthesis

See also
External links
- Sulfisoxazole at the US National Library of Medicine Medical Subject Headings (MeSH)
 - MedlinePlus DrugInfo medmaster-a601049
 - MedlinePlus DrugInfo medmaster-a601115
 - DDB 30455
 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Monday, November 30, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
